{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-465542","form_type":"8-K","ticker":"DLB","cik":"0001308547","company_name":"Dolby Laboratories, Inc.","filed_at":"2026-11-17T21:15:23+00:00","discovered_at":"2026-11-17T21:17:00.572412+00:00","generated_at":"2026-11-17T21:17:12.877555+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Dolby Q4 revenue rises 22% to $374M; GAAP EPS $0.86, non-GAAP $1.25; dividend $0.39","bullets":["Q4 FY2026 revenue was $374M vs $307M a year earlier; GAAP net income $81M ($0.86/diluted share) vs $49M ($0.51).","Non-GAAP Q4 net income was $118M ($1.25/share) vs $96M ($0.99); Dolby repurchased 1.1M shares for about $65M.","FY2026 revenue $1.42B, up 5%; GAAP EPS $2.70 (+3%), non-GAAP EPS $4.36 (+3%); operating cash flow $400M.","Declared $0.39/share dividend payable Dec 9, 2026 to holders of record Dec 1; FY2026 dividends $1.44/share, up 9%."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-465542","json":"https://secwatch.observer/filing/0001193125-26-465542.json","markdown":"https://secwatch.observer/filing/0001193125-26-465542.md","text":"https://secwatch.observer/filing/0001193125-26-465542.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526465542/0001193125-26-465542-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526465542/d144812d8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-17T21:17:12.877555+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}